Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan Makes Quick Progress On Device Reviewer Hiring Pledge

This article was originally published in PharmAsia News

Executive Summary

Japan has already hired 12 of the 13 new device reviewers it pledged to add by year end, bringing its total to 47 as of April, according to a July 6 report. U.S. device industry reps are pleased

You may also be interested in...



AdvaMed Wary Of Japan's Ability To Improve Incremental Product Review

Japan is in need of device industry investment, but without the incentive of data exclusivity, the government needs to counter existing disincentives, says AdvaMed CEO.

Japan Opposition Party To Overhaul National Insurance Agency If It Wins Election, Lawmaker Says

TOKYO - As a means of maintaining the National Health Insurance program and improving Japan's healthcare services, the Social Central Medical Insurance Agency (Chuikyo) structure needs to be streamlined and independent persons, not interested parties alone, should serve as members, Democratic Party of Japan lawmaker Yukio Edano said July 7

Japan Opposition Party To Overhaul National Insurance Agency If It Wins Election, Lawmaker Says

TOKYO - As a means of maintaining the National Health Insurance program and improving Japan's healthcare services, the Social Central Medical Insurance Agency (Chuikyo) structure needs to be streamlined and independent persons, not interested parties alone, should serve as members, Democratic Party of Japan lawmaker Yukio Edano said July 7

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

SC072156

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel